1Blake DR, Meigs JB, Muller DC, et al. Impaired glucose tolerance,but not impaired fasting glucose is associated with increased levels of coronary heart disease risk factors [J ]. Diabetes,2004,53(8):2095-2100.
2Dormandy JA, Charbonnel B, Eckland DJ, et al. Secondary prevention of macro- vascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In maeroVascular Events ) : a randomised controlled trial[J]. Lancet 2005,366(9493) : 1279-1289.
3Maboudou P, Mathieu D, Bachelet H, et al. Detection of oxidative stress. Interest of GC-MS for malondialdehyde and formaldehyde monitoring [J]. Biomed Chromatogr, 2002, 16 (3) : 199-202.
4Houstis N,Rosen ED,Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance[J]. Nature 2006,440 (7086) : 944-948.
5Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome[J]. J Clin Invest 2004,114(12) : 1752-1761.
6Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes [J]. Nature,2001,409 (6818) :307-312.
8Dobrian AD,Davies MJ,Sehriver SD,et al. Oxidative stress in a rat model of obesity-induced hypertension [J]. Hypertension, 2001,37 (Part 2) :554-560.
9Okuno Y, Matsuda M, Miyata Y, et al. Human eatalase gene is regulated by peroxisome proliferator activated receptor-gamma through a response element distinct from that of mouse [J]. Endocr J,2010,57(4) :303-309.
二级参考文献24
1Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease[J]. Diabetes,1988,37(12):1595-1607.
2Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis[J]. Diabetes, 1995,44(4) :369-374.
3Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance[J].Science, 1993,259 ( 5091 ) : 87-91.
4Bochud M, Marquant F, Marques-Vidal PM, et al. Association between C-reactive protein and adiposity in women[J].J Clin Endocrinol Metab, 2009,94(10) : 3969-3977.
5Welsh P, Poliseeki E, Robertson M, et al. Unraveling the directional link between adiposity and inflammation: a bidirectional Mendelian randomization approach [J]. J Clin Endoerinol Metab, 2010,95 (1) : 93-99.
6Orea Soler I,Illan Gomez F,Gonzdlvez Ortega M,et al. Soluble intercellular adhesion molecule-1 and C reactive protein after bariatric surgery[J].Enclocrinol Nutr,2010,57(3) :90-94.
7Isakson P, Hammarstedt A, Gustafson B, et al. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation [J]. Diabetes,2009,58(7) : 1550-1557.
1Hakim FA,Pflueger A. Role of oxidative stress in diabetic kidney disease[J].{H}MEDICAL SCIENCE MONITOR,2010.RA37-RA48.
2King DE,Player M,Everett CJ. The impact of pioglitazone on ADMA and oxidative stress markers in patients with type 2 diabetes[J].Prim Care Diabetes,2012.157-161.
3Forbes JM,Coughlan MT,Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes[J].{H}DIABETES,2008.1446-1454.
4Wagener FA,Dekker D,Berden JH. The role of reactive oxygen species in apoptosis of diabetic kidney[J].{H}APOPTOSIS,2009.1451-1458.
5Toblli JE,Ferrini MG,Cao G. Antifibrotic effects of pioglitazone on the kidney in a rat model of type 2 diabetes mellitus[J].{H}Nephrology Dialysis Transplantation,2009.2384-2391.
6Mattos RT,Bosco AA,Nogueira-Machado JA. Rosiglitazone,a PPAR-γ agonist,inhibits VEGF secretion by peripheral blood mononuclear cells and ROS production by human leukocytes[J].{H}Inflammation Research,2012.37-41.
